The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comparison of two different schemes of neoadjuvant platinum-based concurrent chemoradiotherapy: The experience in the University Hospital Arnau de Vilanova of lleida (Spain).
M. Taberner Bonastre
No relevant relationships to disclose
D. Marquez-Medina
No relevant relationships to disclose
V. Garcia-Reglero
No relevant relationships to disclose
M. Deu-Martin
No relevant relationships to disclose
J. Duran Alama
No relevant relationships to disclose
S. Gomez-Falguera
No relevant relationships to disclose
L. Romero
No relevant relationships to disclose